Petplan has announced the winners of its annual Veterinary Awards.
The awards recognise and celebrate staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Isabella von Mesterhazy, Petplan's Head of Marketing, said: "As the leader in the pet insurance market for over 35 years, we have a rich history of working with veterinary practices across the UK. The Veterinary Awards is a great way to celebrate the fantastic work that goes on helping keep pets healthy and their owners happy."
She added: "This year saw over 11,000 nominations which goes to show the appetite from both staff and clients for celebrating exceptional work. We had an outstanding selection of finalists and I'd like to congratulate all the winners who thoroughly deserve their awards."
The winners for each category are:
VET OF THE YEAR - Laura Pugh, Ashfield House Veterinary Hospital - Long Eaton, NottinghamWhat really stood out was Laura's willingness to go above and beyond the call of duty. As well as Laura's stressful day job she is very involved with the local community. Laura writes an animal column in her local neighbourhood magazine, runs evening talks on a variety of subjects and visits local schools.
VET NURSE OF THE YEAR - Catherine Raw, Broadleys Veterinary Hospital - Stirling, ScotlandCatherine's passion for her role within the practice and her dedication to providing the best service for her clients put her above the other finalists. Catherine is not only committed to her professional role of delivering the highest standard of clinical care for her patients and the best service for her clients, but she also devotes a lot of her own time to animal welfare. Catherine is a fantastic role model for her nurses.
VET SUPPORT STAFF OF THE YEAR - Vivienne Jeffs, Arvonia Animal Hospital - Cheltenham, GloucestershireVivienne's reliability, empathy and selflessness really stood out for the judges. Whether it is knowing the name of a pet owner during telephone conversations, or entertaining toddlers in the waiting area, Vivienne is the type of receptionist vet surgeries dream of. The practice would not be the same without her according to those that nominated her.
VET PRACTICE OF THE YEAR - Bridge Veterinary Surgery - Highbridge, SomersetThe practice's hard work and dedication to their clients really impressed the judges. The practice is open 24 hours a day and the dedication the veterinary, with a small practice of only four staff members, it is a particularly well deserved award.
VET PRACTICE MANAGER OF THE YEAR - Cery Lawson-Tankred, Golden Valley Veterinary Hospital - Nailsea, SomersetCery has worked at Golden Valley for over five years, during which time the practice has seen a large degree of upgrade and reinvigoration. Investments made in new equipment and facilities have meant improved care for an expanding array of animals that come through the surgery doors. It was clear to the judges that Cery is the glue that holds the Golden Valley Veterinary Hospital together.
Idexx Laboratories has announced the addition of pradofloxacin (Veraflox, Bayer Animal Health) to the list of antibiotics that it tests samples sent for culture and sensitivity testing against.
The company says that in the past, only a small percentage of the 350-400 samples it processes every day included a specific request from veterinary surgeons to include sensitivity testing to pradofloxacin. The now-routine testing for pradofloxacin is a positive move toward better clinical outcomes in difficult cases, including specific indications such as wound infections, superficial and deep pyoderma, and in cases with infections resistant to other antibiotics.
Idexx says that as the only next generation fluoroquinolone, pradofloxacin has been shown to be the least likely veterinary fluoroquinolone to select for resistance1, giving vets a lower risk option, when they decide to use an antibiotic from this class.
Matt Jones, Microbiology Manager at Idexx Laboratories said: 'Removing the need to specifically request samples to be tested for sensitivity to pradofloxacin has streamlined the culture and sensitivity testing process for vets and will make it easier for them to adhere to good practice in antibiotic prescription.
"This is important, as antimicrobial resistance is an area of deep international concern. Idexx are pleased to be helping vets identify those cases for which pradofloxacin may be effective and believe that, where indicated, it will lead to improved compliance and excellent clinical outcomes with the added benefit of reducing the likelihood of selecting for resistance, when compared to older generation fluoroquinolones."
The company says this move is in line with BSAVA's PROTECT initiative, which stresses the importance of culture and sensitivity, especially when prescribing antibiotics of the fluoroquinlone class.
Reference
MSD Animal Health UK has announced the launch of Bravecto, which it says is the first and only treatment available for fleas and ticks in dogs that is rapidly effective and offers 12-weeks duration of efficacy.
Bravecto (fluralaner) is the first of a new generation of systemically active ectoparasiticides, the isoxazolines, and will only be available on prescription through veterinary practices. The new product will be available in five strengths of pork liver flavoured palatable chew for different size dogs - one chew per weight band - which MSD says are readily accepted from the hand. Jolian Howell, marketing and technical lead at MSD Animal Health UK said: "Bravecto is a truly unique and exciting innovation which will transform the effective treatment of fleas and ticks - providing protection like never before from a single dose. It is the first in a new generation of products that offer a full 12-week protection and will help keep the treatment of fleas and ticks within veterinary practices."
He continued: "Estimates suggest that flea and tick treatments are applied for just 2.8 months per year so just one dose of Bravecto will immediately deliver much improved levels of treatment for dogs in veterinary care, which is good for the animal and good for the vet." MSD Animal Health says it is investing in the launch of Bravecto with a major marketing and practice support package which aims to raise awareness of fleas and ticks and drive pet owner footfall into practices for flea and tick control.
The new product will be available after BSAVA Congress, where MSD will be giving visitors the opportunity to learn more about it.
The report is the culmination of the work of a joint RCVS and VSC BAME Student Support Working Group, set up to explore key issues in supporting BAME veterinary students during their studies.
The Working Group made a total of 14 recommendations, which included:
Stephanie-Rae Flicker is a recent Royal Veterinary College (RVC) graduate who co-chaired the Working Group alongside Professor Rob Pettitt from the University of Liverpool.
She said: “I hope this encourages and supports our veterinary institutions to actively implement change regarding discrimination faced during studies and placements, nurturing role models and helping affected students develop sense of belonging and community during their studies and beyond.
"Many thanks to all that have contributed to the completion of this Report – we hope the recommendations have a lasting impact, and benefit those both already present and yet to enter our profession."
RCVS/VSC BAME Student Support Working Group Report.
With this new system, you gain points by achieving different ISVPS qualifications.
In 2023, mini modular programmes will also be released to help delegates accumulate more points.
Once enough points have been reached, delegates are awarded the ultimate qualification: an ISVPS Grand Jedi Master General Practitioner (Ed's note: OK, maybe I made up the Grand Jedi bit).
Improve says My Veterinary Career has been launched to tackle the growing problem of career dissatisfaction amongst vets.
A 2019 survey of the veterinary profession by the ies reported that 55.2% of vets said they did not feel rewarded/valued in the profession1.
Additionally, the FVE Survey of the veterinary profession in Europe claimed that in the UK, 40% of vets and nurses wished to leave the industry. In other countries Improve Veterinary Education operates in, 51% in Portugal, 32% in Spain, 27% in Denmark, 25% in Germany and 17% in France also felt the same2.
Improve says that with My Veterinary Career, vets will now have a clearer pathway to advance their careers and they will be able to develop a bespoke learning journey.
This, the company hopes, will help with the recruitment and retention of veterinary professionals across both corporate and private practice and boost practice productivity and revenue.
https://www.improveinternational.com/uk/myveterinarycareer-vets
References
The first phase of research is being conducted this January and February 2023 and will analyse the amount and distribution of UK canine health research funding over the past decade.
Veterinary associations, societies and charities which support canine health research tend to identify funding priorities aligned with their own strategy and scope, taking account of independent peer review from experts in the field of research.
However, the RVC says that as there are many research funders working independently, some important research topics may be overlooked and separately funded projects can inadvertently overlap in their work.
This study endeavours to investigate these issues and consider how resources are prioritised across different areas of canine research.
Participating stakeholders will be asked their opinions on future research funding and this information will contribute to developing a long-term strategy for not-for-profit UK canine health research.
Thereafter, the aim is to create a pilot consultation process for developing a central prioritisation platform for future collaborative canine research.
The RVC’s says it has already got data and support from several major funders but is keen to maximise the scope of this research, so it is now looking for participation from specialist veterinary societies that fund research, and non-university organisations, such as charities, corporates or independent referral practices which conduct their own in-house canine research.
Dr Alison Skipper, Postdoctoral Researcher into Canine Research Funding within VetCompass at the RVC said: “We are really keen to hear from as many non-profit organisations involved with canine health research funding as possible. The breadth and depth of this data is vital to ensure that our findings accurately reflect this sector."
For more information about how to get involved, please visit https://rvc.uk.com/canine-research-funding-analysis.
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
Judges for the UK Rabbit Vet of the Year, the Rabbit Nurse of the Year and the Rabbit Veterinary Practice of the Year awards will be looking for exceptional knowledge of rabbit care and husbandry, and evidence of the winners’ continued commitment to educating the public on how to care for rabbits correctly.
Dr Suzanne Moyes MVB MRCVS, awards judge and Veterinary Director at Burgess Pet Care said: "These awards are our way of saying ‘Thank You’ to the veterinary professionals that are helping to improve the lives of pet rabbits."
Rae Todd, Director of the Rabbit Welfare Association & Fund said: "Rabbits make absolutely fantastic pets but research continues to show that there are still too many rabbit owners failing to meet the correct needs of their rabbits. We’re incredibly grateful for the growing number of vets that are working hard to address this, whether that’s by utilising the available rabbit CPD, taking part in events like Rabbit Awareness Week or generally making their practices more suitable environments for rabbit-owning clients."
Veterinary surgeons and nurses can self-nominate for these awards, and nominations are also being sought from the public.
The winners will each receive a cash prize of £500.
To enter the awards, visit www.burgesspetcare.com/excel-vet-awards.
The Animal Health Trust is appealing to veterinary surgeons and nurses to encourage clients who keep their horses on premises that have been affected by Equine Grass Sickness to sign up to the second year of its nationwide EGS vaccine trial.
Equine Grass Sickness (EGS) occurs predominantly in Europe, with Britain experiencing the highest incidence worldwide. In 2014, 59 cases of EGS were reported through the EGS Surveillance Scheme, but it is likely that this represents only a fraction of cases occurring annually throughout Britain.
Almost all cases of EGS occur in horses with access to grazing. The AHT says there is growing scientific evidence to suggest that the disease may be caused by the bacterium Clostridium botulinum type C, commonly found within soil and capable of producing neurotoxins to which horses are particularly sensitive. EGS occurs when a combination of risk factors trigger the production of these toxins within the horse's intestinal tract, causing damage to the nervous system and paralysis of the gut.
As similar equine diseases such as tetanus and botulism can be prevented by vaccination, it is theoretically possible that a vaccine could prevent EGS. To this end the AHT, in collaboration with the Universities of Edinburgh, Liverpool and Surrey launched the EGS field vaccine trial in 2014 in order to establish whether a vaccine could indeed be effective in reducing the risk of the disease. The trial is funded by a number of sources including Neogen Corporation; Animal Welfare Foundation; Horserace Betting Levy Board; Racing Foundation; Moredun Foundation Equine Grass Sickness Fund; Hong Kong Jockey Club; The British Horse Society and the EB Moller Charitable Trust.
Now entering its second year, the EGS vaccine trial involves enrolled horses and ponies receiving either a course of the C. botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled horses and ponies are closely monitored through regular follow-ups for the duration of the trial.
With 60% of EGS cases occurring during April - June, the highest risk season for EGS is fast approaching. The AHT is appealing to owners who keep their horses on premises that have had at least one case of EGS in the past three years to enrol their horse in the vaccine trial and provide an invaluable contribution to this pioneering research prior to these high risk months. Veterinary practices with clients who fit this description are asked to help the recruitment process by encouraging suitable cases to sign up to the trial.
Dr Jo Ireland, the AHT's Equine Grass Sickness Research Co-ordinator, said: "We have been delighted with the overwhelmingly positive response to the EGS vaccine trial and many owners have welcomed the chance to be a part of such important research. We don't want any eligible horse owners to miss out on the opportunity to contribute towards a potential breakthrough in the prevention of EGS, so we are encouraging more owners to enrol their horses on the trial this year."
To find out more about the vaccine trial or how clients can enrol horses and ponies, visit the AHT's dedicated EGS website www.equinegrasssickness.co.uk or email equinegrasssickness@aht.org.uk.
ATOP 7 Mousse and PYOclean Mousse are presented as a ‘dry shampoo’ in foam form for cats and dogs. They join the company's Dermoscent portfolio of companion animal products, developed to help with the management of scaling disorders, atopic or allergic skin disease and infections.
Both products contain a blend of plant extracts and essential oils from Hemp seed, which LDCA says has a moisturising and restructuring action on the skin. Atop 7 contains lemon tea tree extract, which the company says boosts anti-inflammatory and anti-pruritic activity. PYOclean contains lavender and manuka, which are claimed to have an anti-bacterial action.
LDCA says it has designed the two non-rinse mousses with owner compliance in mind; that used twice-weekly twice-weekly alone or in combination with other supplements or treatments as part of a skincare protocol, they can extend the time between shampoos. They can also be applied quickly to speed patients’ discharge from hospital or used when animals are boisterous or dislike baths.
According to the company, a 2-week veterinary-supervised study looking at the effect of ATOP 7 Mousse on the skin of flea-allergic and atopic dogs, reported a veterinarian general satisfaction score of 8.7/10. Owners of the dogs on the trial reported an 8.7/10 general satisfaction score and a similar score for the product’s ability to soothe irritated skin.¹
The full Dermoscent range, including the new mousses, is available through Vet Direct as well as Henry Schein (selected products) or as a special order through Centaur. ATOP 7 Mousse and PYOclean Mousse are both available in 150ml packs and are priced at £7.94 + VAT each (list price).
For more information visit: http://www.dermoscent.com. A clinical case study by Dr Jean-Loup Mathet on the use of PYOclean Shampoo, Spray and Mousse in a 14-year old West Highland White Terrier with chronic, recurrent, inflammatory, pruritic and seborrhoeic dermatosis is also available online or by request.
The recall is for the following batches only:
Petlife is contacting retailers, veterinary surgeons and wholesale dealers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact Dr J M Ballany on +44 1333 720257 or email: johnballany@btinternet.com.
Merial has announced the launch of a new Blippar app designed to educate horse owners about gastric ulcers.
By using the app - which is available free from the App Store for iPhone or Google Play for Android phones - to scan the company's Gastrogard (omeprazole) adverts, posters or website, clients can watch an educational film with one of the UK's leading specialists in equine ulcers, Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine, demonstrating the signs of ulcers and diagnosis via gastroscopy.
Merial's Equine Marketing and Technical Manager Louise Radford MRCVS said: "With 60% of competition horse and 38% of leisure horses & ponies estimated to have gastric ulcers¹,²,³, it's important that horse owners are aware of the signs of this under-diagnosed condition.
"We know that the number of horses diagnosed and treated for ulcers falls significantly short of incidence levels. We hope that this app will help to raise awareness and prompt more horse owners to consult their vet about gastric ulceration."
A separate Blippar app is also available for horse owners that have been prescribed GastroGard. By scanning the pack, clients can view educational video footage on gastric ulcers, find management tips on treatment and prevention, and set a reminder for future risk periods.
For more information, visit: http://www.equinegastriculcers.co.uk, contact your local Merial equine territory specialist or call Merial Customer Support on 0870 6000123.
Kruuse UK has announced that it will be launching its new Android telemetric ECG system at BEVA 2011.
The original Televet 100 supports transmission of ECG data to a range of approx 100m (330ft), allowing recording and displaying of real time data only within a confined lunging or riding arena. By linking this system to a mobile network via 3G Android phone and a Windows 7 based tablet PC, the new Televet system overcomes this range limitation.
The new system requires the rider/horse to carry a 3G mobile phone which transmits data over the mobile internet, allowing the veterinary surgeon to display and record real time data on any PC/laptop with internet access or mobile internet connection. This also includes GPS information collected by the phone allowing the ECG, heart rate and velocity of the horse to be displayed in parallel.
The Android Telemetric ECG system is specifically targeted towards veterinary applications in the field of sports horses where extended range is particularly useful, such as endurance riding, three day eventing and racing.
Televet software can now also be integrated in Dicom infrastructures in practice for data capture and recording.
Sarah Stokes, Kruuse Equine Territory Manager said: "the flexibility and simplicity of the system along with immediate access to ECG data of patients will be an invaluable diagnostic tool for UK vets allowing vital support for patients and owners wherever they are."
Visitors to the Kruuse stand at BEVA 2011 will also have the chance to win an Acer ICONI W500 tablet worth £500.
The Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons last week issued a reprimand to a veterinary surgeon for reckless certification of an equine passport, having found her to have been "wholly indifferent" as to whether the horse had been vaccinated properly against equine influenza.
Eleri Wyn Jones graduated from the University of Liverpool and qualified as a veterinary surgeon in 2006, before joining The Veterinary Practice on Bala Road in Dolgellau, Gwynedd, where she was also an authorised Local Veterinary Inspector (LVI). The principal of that practice is Iwan Parry, who himself was the subject of a DC hearing involving false certification earlier this year, for which he received a one-month suspension from the Register.
The Committee heard how, in late 2007, as Ms Jones was leaving the practice to begin her rounds, she was asked by a non-veterinary colleague to certify in a horse passport that two vaccinations for equine influenza had been administered. The horse in question was being liveried by a regular client of the practice, to whom the practice regularly dispensed veterinary vaccines (although Ms Jones was unaware of this), but had been recently purchased by someone who was not a registered client.
In evidence, Ms Jones admitted the certification process took her only 30 seconds and that she did not obtain any further information about the certification, either from clinical or non-clinical colleagues; nor did she check any other documentation before signing the passport, but assumed the vaccinations had been administered by a veterinary colleague. The Committee had to decide whether Ms Jones had acted recklessly, and to do so, Ms Jones' Counsel suggested the Committee would need to be satisfied that she "did not care less" whether or not the vaccinations had been given by a veterinary surgeon before signing the passport.
In reaching its decision, the Committee took into account the fact Ms Jones, on her own evidence, was generally familiar with RCVS guidance on certification and, as an authorised Local Veterinary Inspector, had certification training. It stated: "Whilst we recognise that Ms Jones received little or no mentoring from Mr Parry, we are satisfied that she would have been aware of the importance of veterinary certification. She was also aware that Mr Parry had been suspended as an LVI, due to certification issues, which had affected her own authorisation."
In view of these facts, and that Ms Jones made no attempt to obtain verification from any other source despite knowing she had not performed the vaccinations herself, the Committee decided that Ms Jones had been "wholly indifferent" to proper vaccination procedures and was therefore guilty of disgraceful professional conduct for reckless certification.
In reaching its decision on sanction, the Committee wished to remind members that cases involving improper certification would ordinarily result in suspension or removal from the Register. "We strongly disapprove of the circumstances in which Ms Jones certified this horse.
Clients, and external bodies, are entitled to rely upon the integrity of the veterinary surgeon in not certifying that horses have been vaccinated unless they have carried out the vaccinations themselves or have obtained full and proper evidence that vaccination has been carried out by another veterinary surgeon," it said.
In mitigation, however, the Committee took into account Ms Jones' age and inexperience, her previously good record, her good character and the significant number of supporting references from colleagues and clients alike. It was also mindful that any sanction's main purpose was to protect animal welfare and maintain public confidence in the profession, rather than to punish.
Nigel Swayne, chairing the Committee, concluded: "This is not a case where undertakings for training or monitoring are required. This isolated incident was a fateful misjudgement on a single occasion. We consider that the sanction most proportionate to the nature and extent of the charge, the public interest and the interests of Ms Jones is a reprimand."
Pit Bull Terriers, Rottweilers and Bulldogs are the breeds most feared by postmen, according to a survey just announced by esure home insurance. More surprisingly, Jack Russells and Yorkshire Terriers also appeared in the top ten list of breeds likely to prevent the mail getting through.
According to the survey, three quarters (74%) of postmen have admitted to finding some dogs on their post round intimidating. In fact over half (54%) of those polled have considered asking for a change to their round due to intimidating dogs and more than a third (37%) have even thought about leaving their jobs completely.
Nearly half (47%) of all postman questioned are frequently growled at, 39% have been the subject of teeth baring and 54% regularly have to endure aggressive barking. Shockingly, a quarter (26%) of postmen have been bitten by a dog on their post round, whilst 23% of those polled have had their clothes damaged when trying to get away from a dog.
In a bid to try and calm down man's best friend and ensure their safety, more than a third (36%) of postmen have offered a dog bones, biscuits and chews. But just under half (44%) admit bribes often don't work as they've had to run away from a dog on their patch.
POSTMAN'S MOST FEARED DOGS: (per cent of postmen)
Medivet Veterinary Partnership has announced the acquisition of a two-branch practice in Bedfordshire, Ridgeway Veterinary Centre, Flitwick, and Kempston Veterinary Clinic, Bedford, belonging to John Wakely, BVetMed MRCVS.
Current practice vets, John Wakely and Leo Weindrich, as well as all the nursing and reception staff, will remain at the practices. John said: "We are very pleased to be joining the Medivet Group. We will be able to offer our clients a wider range of services and expertise, as well as pass on price reductions for some services, which being part of a larger group enables us to do."
"On a practical level, our clients won't notice much difference. Our staff will remain the same and I will still be their main vet. On a professional level, because the day-to-day administration will be handled by the Medivet head office, I am looking forward to spending more time being a vet. It will give me the time to acquire more expertise in the areas I have always been interested in."
Medivet partner John Smithers said: "John Wakely's practices enjoy an excellent reputation. They will remain local veterinary practices, based, as they always have been, on the high standards of care and strong relationships the staff have developed with their patients and clients over many years. Becoming part of a group will give the practices access to additional skills, facilities and support of staff at other local branches."
This acquisition brings the total number of practices Medivet owns in Bedfordshire to four, the others situated in Biggleswade and Sandy, and brings the total number of practices in the Medivet group to 80.
A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.
The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.
Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.
Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.
Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).
The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.
The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.
The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.
Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.
According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.
Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."
The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.
Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."
Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.
MSD says the campaign will help veterinary nurses and front-of-house staff start the conversation about parasite control by asking clients about their pets' favourite hiding places, where parasites are often found. The supporting campaign tools and materials are designed to help practice staff then uncover pet owner needs to ensure they get the best recommendation.
Amanda Melvin, Marketing Manager at MSD Animal Health said: "Vet nurses and front-of-house staff are usually the first contact pet owners have with the practice. Yet the potential they have to add value to the whole consultation process is often underestimated.
"Our ‘No Hiding’ campaign has been designed to make use of this expertise by helping them find a way of sharing their knowledge. When it comes to pet owners this is usually best achieved by sharing those conversations about the unusual quirks and habits of their pets. That way they can uncover their hiding places and give them the best advice on parasite control."
The ‘No Hiding’ campaign offers a range of resources for practices including in-practice training, social media support, and interactive waiting room resources - demonstrating the practice’s expertise and allowing pet owners to share in the unique hiding habits of their pets.
For further information, contact your MSD Animal Health account manager.
The RCVS Disciplinary Committee has suspended a Co. Tyrone veterinary surgeon from the Register for ten months, having found him guilty of serious professional misconduct relating to three convictions for contravening animal export regulations.
Whilst working as an Authorised Veterinary Inspector in Castlederg for the Department of Agriculture and Rural Development (DARD), William Manson had falsely certified that he had inspected three consignments of sheep presented for assembly at Plumbridge Export Assembly Centre on 16 and 23 August 2009. At this week's two-day hearing, Mr Manson admitted that the convictions he had received at the Strabane Magistrates Court on 26 November 2010 made him unfit to practise veterinary surgery, but said in mitigation that he had examined the sheep nearby at Landahussy, a site he considered more suitable for a large number of animals.
The Committee was satisfied that Mr Manson believed the Landahussy site to be more suitable for large deliveries; the Committee also was satisfied that he did carry out a visual inspection of the sheep at the Landahussy site on 16 and 23 August 2009. However, the information Mr Manson provided on the three certificates was false and misleading. Mr Manson had also been reminded of the importance of complying with government regulations in a disciplinary case in 2004, following convictions for failing to notify DARD about changes in the number of sheep for which he was claiming a premium. The then Committee dismissed the case, deeming the convictions a result of his "genuine but regrettable oversight".
Speaking on behalf of the Committee, Chairman, Prof Peter Lees said: "Mr Manson's actions in certifying that he had examined the sheep at an approved assembly centre when he had not done so amounted to a serious departure from professional standards. If there had been a disease outbreak on either the Plumbridge or Landahussy site, such actions would have rendered contact tracings unreliable and inaccurate."
In mitigation, the Committee accepted medical evidence and Mr Manson's testimony that he was at that time under exceptional stress. He was working long hours in difficult circumstances without an assistant, and was under considerable personal pressure as a result of his wife's serious illness. It also took into account his age (66), exceptional testimonials produced on his behalf, and the impact on the community he served.
Prof Lees said: "The Committee has concluded that the removal of Mr Manson's name from the Register is neither proportionate nor necessary in the public interest nor to protect the welfare of animals. A proportionate sanction in this case is to suspend Mr Manson's name from the Register for a period of ten months."
Each candidate will produce a written reply to two questions of their choice, which will be included on their candidate profile webpage ahead of the start of the election.
The 14 candidates who are standing in this year’s election for the three available elected places on RCVS Council are:
The biographies and election statements for each candidate are available to read at www.rcvs.org.uk/vetvote24.
The three candidates with the most votes will join Council for their four-year terms at the College’s AGM in July.
The College says it will only accept one question per person and questions must be decent.
Offensive, defamatory and inaccurate questions will not be passed on to candidates.
You can email your question to: vetvote24@rcvs.org.uk
And the winners are:
Laurent Garosi (The Bourgelat Award for outstanding international contributions to the field of small animal practice), Sarah Girling (The Simon Award for outstanding contributions in the field of veterinary surgery), Kit Sturgess (The Woodrow Award for contributions to the advancement of small animal medicine), Martin Hawes (The Amoroso Award for outstanding contributions to small animal studies), Daniella Dos Santos (The J.A. Wight Memorial Award for an outstanding contribution to the welfare of companion animals) and Claire Bessant (The Ray Butcher Award for an individual who has made a significant contribution to animal welfare in the community).
Other winners included: Marzia Stabile (The Melton Award for the first named author of the best original research article on small animal surgery published in the Journal of Small Animal Practice), Ross Bond (The PetSavers Veterinary Achievement Award for the first author of the most valuable full research paper published following a BSAVA PetSavers' grant) and Rosanne Jepson (The Blaine Award for outstanding contributions to the advancement of small animal veterinary medicine or surgery).
BSAVA Honorary Secretary, Krista Arnold said: “Congratulations to all those that are receiving an accolade.
“All the nominations were exceptional, making judging particularly difficult this year.”
Ceva has announced that its cardiology webinar series, which attracted over 1,600 veterinary professionals when viewed live, is now available to view on-demand by visiting www.cardaliscpd.co.uk.
The webinars, which cover the management of heart failure, are presented by some of the UK's leading veterinary cardiology specialists:
Each webinar lasts for around 1.5 hours. CPD certificates are then available after answering questions relating to each webinar.
For further information visit www.cardaliscpd.co.uk.
The National Office of Animal Health Code of Practice Committee has found MSD Animal Health in breach of the NOAH Code on promotion for its advertisment for Equilis Prequenza.
The advert appeared in three separate issues of Veterinary Times (15, 22 and 29 September 2014), on the rear back cover of the 2014 BEVA Congress proceedings, and on the inside back cover of the 2014 Congress Planner. It contained the phrase “Neuraminidase antibodies provided a degree of protection in the case of HA strain/vaccine mismatch”, when viewed against the context of the advertisement headed ‘Why have part when you can have it all?”.
The Committee’s view was that the item in the context of the advertisement was intended to mean, and did convey, the meaning that the inclusion of NA antigens in an equine vaccine gave that vaccine a clinical advantage over vaccines which did not. This claim was not substantiated. Accordingly, the Committee found the phrase in breach of Code of Practice Clauses 4.1(iii) misleading, 4.1(vi) contained an exaggerated claim, 4.1(vii) implied it had a special merit which was not substantiated, 4.2(i) was not accurate and 4.2(ii) was not based upon an up-to-date evaluation of all the evidence.
Full details of the Committee’s rulings can be found on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
The RCVS has announced that the Code of Professional Conduct has been updated to restrict - from April 2016 - the use of the word specialist and its derivatives in veterinary practice marketing and promotional materials, except when referring to an RCVS Recognised Specialist.
Alternatives for practitioners who want to describe a special area of expertise in their marketing materials, but who are not on the RCVS list of Specialists include: 'Special interest in ...', 'Experienced in ...', 'Advanced qualifications in ...', or, for those who hold the status, 'Advanced Practitioner'.
The College says the changes will also apply to European Veterinary Specialists fully recognised by the European Board of Veterinary Specialisation, who will now need to join the RCVS list if they wish to use the title in the UK. However, European Specialists will be offered a simplified application process and a 50% reduction in the fee, because their revalidation is carried out by their specialist European college.
The College has also extended the deadline for new applications for Specialist Status to 30th September 2015. The deadline for re-applications by existing RCVS Specialists remains 14th August 2015.
In addition to changing the Code, the College has also amended Chapter 23 of its supporting guidance ('Advertising and publicity') to give more detailed advice on use of the terms 'specialist' and 'specialising in' in the context of advertising and referrals.
Gordon Hockey, RCVS Registrar, said: "Specialist status is not easy to achieve. Those who hold it have achieved a postgraduate qualification at a minimum of Diploma level and have satisfied us that they make an active contribution in their speciality, for example, through publishing academic papers.
"The change to the Code of Professional Conduct is therefore intended to ensure the integrity of the specialist list and title, so that those who do not have RCVS-recognised qualifications, experience and expertise do not claim or imply they hold such a status.
"These changes will benefit the public and, ultimately, animal welfare by clearly identifying those who have specialised knowledge and skills. They should also aid members of the broader profession in the UK when they are deciding who they should refer cases to.
"We recognise this represents a significant change which is why we have allowed a 'bedding in' period before the change comes into force, as well as extending the deadline for applications."
To find out more about applying for Specialist status, visit www.rcvs.org.uk/specialists. The List of RCVS Specialists is available at www.rcvs.org.uk/listofspecialists. Details of the updates made to the Code can be found at www.rcvs.org.uk/vetcode. These changes have also been reflected in the RCVS Code of Professional Conduct app which can be downloaded from www.rcvs.org.uk/codeapp.
Nick Hicks, HSBC’s Corporate Area Director in Thames Valley, said: "HSBC has enjoyed a highly effective and longstanding business relationship with Medivet, which went from the purchase of a small veterinary practice in Hendon, North London in 1987, to the acquisition of over 140 practices across the UK today. This latest financing package supports the continuing expansion strategy of this successful and acquisitive business."
Dr Arnold Levy (pictured right), Chief Executive Officer at Medivet, said: "This is the second wave of our acquisition strategy which will see us, as a privately owned company, expand our offering of veterinary practices across the country. Following the success of last year’s acquisitions, which were also funded by HSBC, we have continued our expansion across the UK a lot quicker than anticipated. This is significant progress for our business and testament to our strong financial backing."